{"id":"W4400019582","doi":"10.1016/j.euo.2024.05.013","title":"Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D","year":2024,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System; Sunnybrook Hospital; Jewish General Hospital","funders":"","keywords":"Medicine; Enzalutamide; Abiraterone acetate; Prostate cancer; Prednisone; Internal medicine; Pembrolizumab; Clinical endpoint; Oncology; Interquartile range; Cohort; Urology; Cancer; Clinical trial; Surgery; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00147068,0.0005879183,0.0009111072,0.0002442244,0.0004857495,0.0009272829,0.0005609636,0.0005119057,0.002307209],"category_scores_gemma":[0.001359848,0.0003057142,0.001782075,0.0004635266,0.0003586552,0.0005714211,0.0005093422,0.001240761,0.0005098126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001424037,"about_ca_system_score_gemma":0.002059672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008244125,"about_ca_topic_score_gemma":0.01345291,"domain_scores_codex":[0.9993621,0.0001970184,0.00006644816,0.0001541522,0.0001025554,0.0001177007],"domain_scores_gemma":[0.9987817,0.0001291718,0.0003043895,0.0001378514,0.0001414946,0.0005053758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5145087,0.01919044,0.3077048,0.001430822,0.007023829,0.000569906,0.0009614161,0.001603448,0.01536809,0.0002881427,0.016865,0.1144855],"study_design_scores_gemma":[0.1690663,0.132176,0.6611865,0.0003928397,0.007044598,0.001652854,0.0009033111,0.001874275,0.004036353,0.0004142374,0.02110089,0.0001519569],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989777,0.002810359,0.0001947111,0.0003684189,0.00006131087,0.0005405093,0.005032101,0.00002669134,0.001188771],"genre_scores_gemma":[0.9886606,0.001364573,0.0004542985,0.0007027068,0.0001093614,0.0002983495,0.007458194,0.00001294275,0.0009389537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008244125,"threshold_uncertainty_score":0.01639229,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0173763584920934,"score_gpt":0.2946632417206965,"score_spread":0.2772868832286031,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}